Specifically, the Mountain View, Calif.-based company said it will pair its True 3D system with HP’s Zvr Interactive Virtual Reality Display and workstation. True 3D lets physicians interact with CT or MR images as they would with real physical objects, allowing medical professionals such as radiologists and cardiologists to be able to see parts of an individual patient’s anatomy in an open, 3D space.
EchoPixel pitches its True 3D system as a tool that surgeons and physicians can use to reach a diagnosis or plan complex clinical procedures.
Neither side is disclosing financial details. But their agreement is a complementary fit. EchoPixel said that HP’s Zvr display and Z440 workstation are both customized to the EchoPixel True 3D Viewer FDA-cleared regulatory requirements.
EchoPixel has explored new clinical applications for its technology at beta test sites. That, combined with HP’s established global relationships with medical institutions, could help accelerate the use of virtual reality technology in medical imaging, EchoPixel said in its deal announcement.
EchoPixel’s True 3D system has been marketed in the U.S. since March 2015.
EchoPixel CEO Ron Shilling said in prepared remarks that he sees the partnership with HP as “a formative moment in the development and distribution of virtual reality in the medical imaging space.”